Services
Expertises
Resources
Who we are
Closed

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022

R&D partnering mission for Canadian SMEs

Funding available
Varies by project
Deadline
Unspecified
Location
Canada
Who can apply
Small and medium-sized enterprises
See full eligibility

Overview

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 was open to small and medium-sized enterprises seeking personalized medicine partnering opportunities in Germany. Technologies of interest included biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA, and CRISPR.

At a glance

Funding available

Varies by project

Financing goals
  • Develop strategic partnerships
  • Conduct research and development activities
  • Access new markets

Eligible candidates

Location
  • Canada
Eligible Industries
All industries
Annual revenue
All revenue ranges
Organisation size
All organization sizes
Audience
All groups
Legal structures
All legal structures

Receipt of requests is now closed

Get notified about updates to this grant.

Availability timeline

2023
Periods: 1

Eligibility

Who is eligible?

  • Small and medium-sized enterprises

Additional information

  • The page is archived and will not be updated.
  • Technologies and products of particular interest include biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, advanced therapies such as cell and gene therapies, CAR-T cells and tissue engineered therapies, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA and CRISPR.

Official sources

Add helloDarwin as a preferred source on Google

Frequently Asked Questions about the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 Program

What is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 was open to small and medium-sized enterprises seeking personalized medicine partnering opportunities in Germany. Technologies of interest included biologics and advanced therapies, antibody-based therapeutics and other targeted biologics, and lipid nanoparticle platforms with genetic medicine payloads such as mRNA, siRNA, and CRISPR.

Who is eligible for the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program?

To be eligible for the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program, you must: Small and medium-sized enterprises

Who can I contact for more information about the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?

You can contact National Research Council Canada (NRC).

Where is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 available?

The Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 program is available across Canada.

Is the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 a grant, loan, or tax credit?

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 is a Partnering and Collaboration

Who are the financial supporters of the Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022?

Canadian personalized medicine R&D partnering mission to Germany – October 17-21, 2022 is funded by National Research Council Canada (NRC)